INDEGENE
|
The Current P/B Ratio of INDEGENE is 9.46.
Share Price | ₹551.1 | Apr 08,2025 |
Market Cap | ₹13,226.4 Cr | |
Book Value | ₹1,397.7 Cr | Mar2024 - Consolidated Results |
Price/Book | 9.46x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,226.4 Cr] as on Apr 08,2025
(/) Book Value [ ₹1,397.7 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 9.46x ]
Thus, for INDEGENE , the investors are currently willing to pay '9.46 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 1,397.70 | 9.46 | 13,226.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.36 | 405,188.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 10.54 | 143,074.0 |
CIPLA LTD | 26,619.90 | 4.35 | 115,768.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.02 | 109,809.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.29 | 92,503.5 |
MANKIND PHARMA LTD | 9,339.84 | 10.35 | 96,689.8 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.36 | 86,490.8 |
LUPIN LTD | 14,175.80 | 6.39 | 90,520.9 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.13 | 63,702.3 |
ABBOTT INDIA LTD | 3,658.73 | 17.08 | 62,501.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.13x |
Max industry PB | 17.08x |
Median industry PB | 6.39x |
Average industry PB | 8.21x |
You may also like the below Video Courses